Ruby the Greyhound was diagnosed with osteosarcoma in December 2016 and began the ELIAS cancer immunotherapy (ECI®). Today, Ruby is thriving and her story was recently featured on a Kansas City local news channel.

Learn more about Ruby, one of five long-term survivors from the ELIAS preliminary study.

Read the story